Skip to main content

Clearance on Moderna Vaccine Sets Roadmap For Pfizer, Johnson & Johnson

New Delhi: With Moderna’s coronavirus vaccine getting approval from the Drugs Controller General of India (DCGI) for emergency use, a roadmap has been paved for other international vaccine makers like Pfizer and Johnson & Johnson to deliver in India. The drug regulator on Tuesday granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna’s American-made COVID-19 vaccine, making it the fourth vaccine to be available in India for emergency use.

While details of the rollout plan are yet to be released, reports said that for now, Cipla will be importing donated vaccines by Moderna as commercial agreements are still being processed. So far, Serum Institute’s Covishield, Bharat Biotech’s Covaxin and Russia’s Sputnik were cleared for the vaccination drive.

“Cipla Limited is supporting Moderna Inc with the regulatory approval and importation of vaccines to be donated to India. At this stage, there is no definitive agreement on commercial supplies,” the Mumbai-based pharma said in a statement.

Of all the four vaccines, Moderna has the highest effectiveness of 94% against coronavirus disease.

What does this mean for international vaccines in India?

“Our efforts to invite and to have other internationally developed vaccines specifically Pfizer and J&J also continue. Those processes are on. We are also looking at increasing the production of availability of vaccines that are being manufactured in our country,” NITI Aayog Member (Health) and COVID Task Force chief Dr VK Paul said at a press conference.

Will Johnson & Johnson Get Its Single-Dose Vaccine to India?

Soon after the announcement of Cipla and Moderna, Johnson & Johnson hinted that their single-dose vaccine may soon be available in India.

“As per DCGI’s recent announcement, now no requirement of conducting bridging clinical studies of COVID vaccines in India. We’re in discussions with GoI & exploring how best to accelerate our ability to deliver our single-dose vaccine to India,” Johnson & Johnson’s India spokesperson said to ANI.

When Will Pfizer’s Covid Vaccine be Approved?

Recently, Pfizer CEO Albert Bourla had said that it was in the “final stages” of getting approval for its COVID-19 vaccine in India. Dr Paul had also said in press briefings that the government has had “multiple sessions” with Pfizer and it is in consideration of approving the vaccine for India.

With the approval of Moderna, the government said that the deal on Pfizer vaccine may be closed soon. This could boost the vaccination process among children of age 12 to 18, paving way for the reopening of schools and other educational institutes.



source https://www.india.com/news/india/clearance-on-cipla-moderna-vaccine-sets-roadmap-for-pfizer-johnson-johnson-4777057/

Comments

Post a Comment

Popular posts from this blog

UK Makes Face Mask Mandatory As Omicron Virus Spreads, 22 Test Positive

London: Face coverings are mandatory in shops and public transport from Tuesday as part of targeted measures” to slow the spread of the Omicron variant, 22 cases of which have now been detected in the UK after Scotland and England reported further infections. Individuals linked with all new cases, identified in the East Midlands, the East of England, London, and the North West, are all isolating and the UK Health Security Agency (UKHSA) said work is underway to identify any links to travel to southern Africa. “It is very likely that we will find more cases over the coming days as we are seeing in other countries globally and as we increase case detection through focused contact tracing, said Dr Jenny Harries, UKHSA Chief Executive. The enhanced measures, announced last week as a precaution while more information is gathered and assessed on the new variant’s transmissibility and any possible effect on current COVID-19 vaccines, also include compulsory PCR tests on arrival for all int...
Post a Comment
Read more

Weekly RT-PCR Mandatory For Unvaccinated Employees In Kerala. Details Here

Thiruvananthapuram : In an effort to make everyone get vaccinated, Kerala Chief Minister Pinarayi Vijayan on Tuesday said anyone not following COVID prevention measures, like vaccination, will not be provided free treatment. He also said that non-vaccinated teachers and employees who work from offices or interact with public will have to submit weekly results of RT-PCR tests. “No more free treatment for those who do not cooperate with Covid prevention measures. Non vaccinated teachers and employees who work from offices or interact with public, will have to submit weekly results of RT-PCR tests, paid for by themselves, to ensure safety of all,” Vijayan said in a tweet. No more free treatment for those who do not cooperate with Covid prevention measures. Non vaccinated teachers and employees who work from offices or interact with public, will have to submit weekly results of RTPCR tests, paid for by themselves, to ensure safety of all. — Pinarayi Vijayan (@vijayanpinarayi) November ...
Post a Comment
Read more